A twelve-week course of atorvastatin was shown to significantly reduce arterial stiffness (a predictor of CVD and vascular dysfunction), registering a 12% reduction, in 29 long-standing RA patients with moderate disease activity, assessed using pulse-wave analysis, although the treatment did not lead to a reduction in CRP levels [54]. This evidence concerns the gene CRP and rheumatoid arthritis.